Autolus Therapeutics plc Profit Margin

The latest profit margin for AUTL is -311.95% as of March 2026. That compares with -2642.69% in the prior-year period — up 88.2% year over year. That is below the Healthcare sector average of 15.29%. Investors often review this figure alongside Autolus Therapeutics plc's historical trend and sector peers before judging valuation or financial health.

Over the past year, AUTL's profit margin moved from -2642.69% to -311.95% — a 88.2% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Autolus Therapeutics plc's valuation or profitability profile.

Against Healthcare companies, AUTL currently prints -311.95% for profit margin, while the sector average sits near 15.29%. That is roughly 2139.9% below the sector mean. Large gaps often invite a closer look at Autolus Therapeutics plc's growth, margins, and balance sheet.

Profit Margin shows how effectively Autolus Therapeutics plc converts resources into returns. At -311.95%, AUTL may look efficient or underperforming depending on peer benchmarks and trend direction. That compares with -2642.69% in the prior-year period — up 88.2% year over year. Pair the percentage with revenue growth and leverage for a fuller health check.

After noting AUTL's profit margin (-311.95%), review year-over-year change from -2642.69%, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.